Monthly Prescribing Reference7h
Tamibarotene Fails to Meet Primary Endpoint in Myelodysplastic Syndrome Trial
Syros Pharmaceuticals announced that its phase 3 trial of tamibarotene in combination with azacitidine did not meet the primary endpoint for the treatment of myelodysplastic syndrome.
Monthly Prescribing Reference10h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
In the univariate analysis, those on an SGLT-2i/GLP-1 RA had a reduced risk for mortality, incident MI, and composite.
Monthly Prescribing Reference11h
US Physicians Rarely Disciplined for Spreading Medical Misinformation
Spreading medical misinformation to the public and providing misinformation to patients receiving treatment were among the least common reasons for discipline. A large study suggests that, across the ...
Monthly Prescribing Reference11h
FDA Denies Full Approval of Obeticholic Acid for Primary Biliary Cholangitis
The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.
Monthly Prescribing Reference11h
Virtual Yoga Classes Aid Chronic Low Back Pain
(HealthDay News) — Virtual yoga classes may be a feasible, safe, and effective treatment option for chronic low back pain (CLBP), according to a study published online Nov. 1 in JAMA Network Open.